CFDE Data Portal | Search LINC02432

	Label	Description
	LINC02432 Gene (Entity type)	ENSG00000248810 - long intergenic non-protein coding RNA 2432
	GSE108464 AZ-628 11 v 12 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE234148 HDAC inhibition 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 9 v 14 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE225901 dexamethasone 2 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE99875 everolimus 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE225901 dexamethasone 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE208350 H-7 Huh-7 JHH-7 0 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE147815 GSE147817 LSD1 inhibition McCoy 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE135514 dasatinib 2 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS

LINC02432

ENSG00000248810 - long intergenic non-protein coding RNA 2432

GSE108464 AZ-628 11 v 12 human up

A Gene Set from LINCS

GSE234148 HDAC inhibition 0 v 1 human up

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 9 v 14 human dn

A Gene Set from LINCS

GSE225901 dexamethasone 2 v 3 human dn

A Gene Set from LINCS

GSE99875 everolimus 2 v 0 human dn

A Gene Set from LINCS

GSE225901 dexamethasone 0 v 1 human up

A Gene Set from LINCS

GSE208350 H-7 Huh-7 JHH-7 0 v 8 human dn

A Gene Set from LINCS

GSE147815 GSE147817 LSD1 inhibition McCoy 2 v 3 human up

A Gene Set from LINCS

GSE135514 dasatinib 2 v 3 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.